InvestorsHub Logo
Followers 6
Posts 896
Boards Moderated 0
Alias Born 12/23/2015

Re: carusso post# 4359

Sunday, 07/03/2016 7:56:18 PM

Sunday, July 03, 2016 7:56:18 PM

Post# of 233287
Essentially PRO-140 offers a vastly superior safety profile with superior convenience. In any case I consider efficacy to be a given. If a drug doesn't work then it is not even brought to the table for comparison.

In my opinion the biggest headwaters they will face will be marketing PRO-140 after FDA approval. CytoDyn does not have the infrastructure needed to roll out a drug. They will need to partner or be acquired.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News